晚期和选定的实体瘤的临床试验
总计19519个结果
-
University Health Network, TorontoPrincess Margaret Hospital, Canada完全的
-
Taiho Oncology, Inc.终止
-
AstraZenecaParexel终止
-
Vall d'Hebron Institute of OncologyTaisho Pharmaceutical Co., Ltd.; Roche Pharma AG; Iqvia Pty Ltd; Janssen, LP招聘中
-
Hoffmann-La Roche完全的
-
Second Affiliated Hospital of Soochow UniversitySciClone Pharmaceuticals招聘中
-
Shanghai Kanda Biotechnology Co., Ltd.尚未招聘
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
Bristol-Myers Squibb主动,不招人
-
TakedaTakeda Development Center Americas, Inc.主动,不招人晚期或转移性实体瘤美国, 中国, 克罗地亚, 日本, 拉脱维亚, 波兰, 巴西, 立陶宛, 瑞士
-
Novartis Pharmaceuticals完全的
-
Merck KGaA, Darmstadt, Germany完全的
-
Gustave Roussy, Cancer Campus, Grand Paris完全的
-
AstraZeneca完全的Advanced Solid Metastatic Tumor英国
-
University Hospital, Basel, SwitzerlandResearch Center for Clinical Neuroimmunology and Neuroscience Basel尚未招聘
-
Hervor TherapeuticsCancer Institute and Hospital, Chinese Academy of Medical Sciences; Women's Hospital School... 和其他合作者招聘中